Progress in Simulating Clinical Trials

The Archimedes Model is a discrete event simulation model of the interaction of human physiology, human behavior, and the healthcare delivery system. The model is used in various ways but a key use is for simulating clinical trials to obtain insight into the costs and benefits of new therapeutic agents (medications) and alternative treatment and screening strategies.

Building this model was a complex undertaking that was initiated over 15 years ago as a research project within Kaiser Permanente. This presentation will overview the model; motivate the reasons for building such a model; present examples of its use; and highlight challenges in building and maintaining it.

Speaker: Marc-david Cohen is Chief Science Officer at Archimedes Inc. where he is responsible for the Archimedes model, a core asset of the company. He is also responsible for delivery of consulting projects and actively participates in product direction and development. Previously he was Vice President of Research and Development at Fair Isaac Corporation where he was responsible for core analytic capabilities in new product offerings and directions in risk prediction. And prior to that, he served in various research and product positions at SAS Institute. He has a PhD in Operations Research from the University of North Carolina, Chapel Hill, and an undergraduate degree in mathematics from Brandeis University.

NEC Auditorium.